Systemic Lupus Erythematosus Clinical Trials in Memphis, Tennessee

5 studies are recruiting for systemic lupus erythematosus in Memphis, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

   This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different doses of BI 3000202 and aims to find the best dose for people with this condition. Participants are pu…

   Stage

   Phase 2

   Ages

   18 to 74

   Site

   Shelby Research LLC, Memphis, Tennessee

   Locations

   140 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07409181 on ClinicalTrials.gov

2. A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

   The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti-malarial, with or without GC; in patients not in LLDAS at enrolment. Patients will be naïve to any…

   Stage

   Phase 3

   Ages

   18 to 70

   Site

   Research Site, Memphis, Tennessee

   Locations

   107 in total

   Run by

   AstraZeneca

   See if you can join NCT07430306 on ClinicalTrials.gov

3. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

   Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Sjorgren's disease (SjD) is a chronic, multisystem autoimmune disease characterized by lacrimal and salivary gland inflammation, with resultant dryness of the eyes and mouth and occas…

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Private Practice - Dr. Ramesh C. Gupta /ID# 275826, Memphis, Tennessee

   Locations

   11 in total

   Run by

   AbbVie

   See if you can join NCT06977724 on ClinicalTrials.gov

4. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

   The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE). Another goal is to learn about the safety of VENT-03 and how it is processed by the body. The main questions it aims to…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Investigative Site, Memphis, Tennessee

   Locations

   32 in total

   Run by

   Ventus Therapeutics U.S., Inc.

   See if you can join NCT07260877 on ClinicalTrials.gov

5. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

   The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).

   Stage

   Phase 3

   Ages

   12 to 100

   Site

   Shelby Research LLC, Memphis, Tennessee

   Locations

   143 in total

   Run by

   Novartis Pharmaceuticals

   See if you can join NCT06133972 on ClinicalTrials.gov